TEAS RF New Application

ULTRACARE

Ultragenyx Pharmaceutical Inc.

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 88000625
Filing Date: 06/14/2018

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88000625
MARK INFORMATION
*MARK \\TICRS\EXPORT17\IMAGEOUT 17\880\006\88000625\xml1\ RFA0002.JPG
SPECIAL FORM YES
USPTO-GENERATED IMAGE NO
LITERAL ELEMENT UltraCare
COLOR MARK YES
COLOR(S) CLAIMED
(If applicable)
The color(s) purple and green is/are claimed as a feature of the mark.
*DESCRIPTION OF THE MARK
(and Color Location, if applicable)
The mark consists of the term UltraCare in which the U and C are capitalized and the component Ultra ranges from light to dark purple from the top to bottom and the component Care ranges from light to dark green from top to bottom. The characters are all in the same font but the individual letters are relatively thicker in the Care component.
PIXEL COUNT ACCEPTABLE NO
PIXEL COUNT 1456 x 316
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Ultragenyx Pharmaceutical Inc.
*STREET 60 Leveroni Court
*CITY Novato
*STATE
(Required for U.S. applicants)
California
*COUNTRY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
94949
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY OF INCORPORATION California
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 036 
*IDENTIFICATION Patient advisory, support and consultancy services regarding patient access to treatment; providing information and guidance in connection with health insurance benefit plans and other patient financial assistance resources; insurance and medical and pharmaceutical access consultation services, namely, assisting patients and their caregivers to identify the scope of coverage offered by patient medical and pharmaceutical insurance and to identify other financial assistance resources for payment of patient treatment; insurance consultation services, namely, assisting patients and their caregivers to obtain authorization and payment for medical and pharmaceutical costs
FILING BASIS SECTION 1(a)
       FIRST USE ANYWHERE DATE At least as early as 11/15/2017
       FIRST USE IN COMMERCE DATE At least as early as 11/15/2017
       SPECIMEN FILE NAME(S) \\TICRS\EXPORT17\IMAGEOUT 17\880\006\88000625\xml1\ RFA0003.JPG
       SPECIMEN DESCRIPTION a screenshot of Applicant's website displaying the applied-for mark and promoting Applicant's services
ADDITIONAL STATEMENTS SECTION
ACTIVE PRIOR REGISTRATION(S) The applicant claims ownership of active prior U.S. Registration Number(s) 5124554 and 5124555.
ATTORNEY INFORMATION
NAME Anne H. Peck
FIRM NAME Cooley LLP
INTERNAL ADDRESS Suite 700
STREET 1299 Pennsylvania Avenue NW
CITY Washington
STATE District of Columbia
COUNTRY United States
ZIP/POSTAL CODE 20004
PHONE 650-843-5095
EMAIL ADDRESS trademarks@cooley.com
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
OTHER APPOINTED ATTORNEY John W. Crittenden, Janet L. Cullum, Brendan J. Hughes, John Paul Oleksiuk, Peter J. Willsey, Vincent J. Badolato, Michael Bleicher, Susan Piascik Christoff, Brian Focarino, Rebecca Givner-Forbes, Timothy Hance, Shannan Higgins, Ariana Gallisá Hiscott, Chantal Hwang, Judd Lauter, Lori Levine, Kathlyn Querubin, Shane Rumbaugh, Cynthia Smuzynska, and Karen K. Won
CORRESPONDENCE INFORMATION
NAME Anne H. Peck
FIRM NAME Cooley LLP
INTERNAL ADDRESS Suite 700
STREET 1299 Pennsylvania Avenue NW
CITY Washington
STATE District of Columbia
COUNTRY United States
ZIP/POSTAL CODE 20004
PHONE 650-843-5095
*EMAIL ADDRESS trademarks@cooley.com; peckah@cooley.com; myoung@cooley.com; eortiz@cooley.com
*AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
FEE INFORMATION
APPLICATION FILING OPTION TEAS RF
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 275
*TOTAL FEE DUE 275
*TOTAL FEE PAID 275
SIGNATURE INFORMATION
SIGNATURE NOT PROVIDED
SIGNATORY'S NAME NOT PROVIDED
SIGNATORY'S POSITION NOT PROVIDED
DATE SIGNED NOT PROVIDED



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

Serial Number: 88000625
Filing Date: 06/14/2018

To the Commissioner for Trademarks:

MARK: UltraCare (stylized and/or with design, see mark)

The literal element of the mark consists of UltraCare.
The color(s) purple and green is/are claimed as a feature of the mark. The mark consists of the term UltraCare in which the U and C are capitalized and the component Ultra ranges from light to dark purple from the top to bottom and the component Care ranges from light to dark green from top to bottom. The characters are all in the same font but the individual letters are relatively thicker in the Care component.
The applicant, Ultragenyx Pharmaceutical Inc., a corporation of California, having an address of
      60 Leveroni Court
      Novato, California 94949
      United States

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

       International Class 036:  Patient advisory, support and consultancy services regarding patient access to treatment; providing information and guidance in connection with health insurance benefit plans and other patient financial assistance resources; insurance and medical and pharmaceutical access consultation services, namely, assisting patients and their caregivers to identify the scope of coverage offered by patient medical and pharmaceutical insurance and to identify other financial assistance resources for payment of patient treatment; insurance consultation services, namely, assisting patients and their caregivers to obtain authorization and payment for medical and pharmaceutical costs

In International Class 036, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 11/15/2017, and first used in commerce at least as early as 11/15/2017, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in the class of listed goods/services, consisting of a(n) a screenshot of Applicant's website displaying the applied-for mark and promoting Applicant's services.
Specimen File1



Claim of Active Prior Registration(s)
The applicant claims ownership of active prior U.S. Registration Number(s) 5124554 and 5124555.

The applicant's current Attorney Information:
      Anne H. Peck and John W. Crittenden, Janet L. Cullum, Brendan J. Hughes, John Paul Oleksiuk, Peter J. Willsey, Vincent J. Badolato, Michael Bleicher, Susan Piascik Christoff, Brian Focarino, Rebecca Givner-Forbes, Timothy Hance, Shannan Higgins, Ariana Gallisá Hiscott, Chantal Hwang, Judd Lauter, Lori Levine, Kathlyn Querubin, Shane Rumbaugh, Cynthia Smuzynska, and Karen K. Won of Cooley LLP
      Suite 700
      1299 Pennsylvania Avenue NW
      Washington, District of Columbia 20004
      United States
      650-843-5095(phone)
      trademarks@cooley.com (authorized)


The applicant's current Correspondence Information:
      Anne H. Peck
      Cooley LLP
      Suite 700
      1299 Pennsylvania Avenue NW
      Washington, District of Columbia 20004
      650-843-5095(phone)
      trademarks@cooley.com;peckah@cooley.com; myoung@cooley.com; eortiz@cooley.com (authorized)
E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional processing fee of $125 per international class of goods/services.

A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: Not Provided    Date: Not Provided
Signatory's Name: Not Provided
Signatory's Position: Not Provided
Payment Sale Number: 88000625
Payment Accounting Date: 06/15/2018

Serial Number: 88000625
Internet Transmission Date: Thu Jun 14 14:30:00 EDT 2018
TEAS Stamp: USPTO/BAS-XXX.XXX.XXX.XX-201806141430006
21120-88000625-6109e1a02e9b414e4b3e13efe
c3ab2991e7aaa6aadb2d1d37bf57de28ebc98cdd
-DA-875-20180614141101523662

TEAS RF New Application [image/jpeg]

TEAS RF New Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed